Artificial Intelligence on Pulmonary Function Tests Improves Respiratory Disease Diagnosis.

01/01/2019

Respiratory research: Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo – a post-hoc analysis of the BACE randomized controlled trial.

01/01/2019

Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomized double-blind placebo-controlled trial.

Thorax 7/01/2013
07/01/2013

» http://www.ncbi.nlm.nih.gov/pubmed/

The Azithromycin in Severe Asthma (AZISAST) study: accurate classification into the five Severe Asthma Research Program (SARP) clinical phenotypes of severe asthma.

Chicago, USA
01/01/2011

» http://www.ncbi.nlm.nih.gov/sites/

Nationaal multidisciplinair Symposium : Severe chronic airway disease: Failure of basic treatment, Vilvoorde 2010. Rhinosinusitis and COPD.

Vilvoorde, Belgium
01/01/2010

» http://www.ncbi.nlm.nih.gov/sites/

BVKB-SBBC Annual Symposium 2007, ULB Brussels, 13/10/2007: Potential of BAL fluid examination for the diagnosis of pulmonary sarcoidosis.

Brussel, Belgium
13/10/2007

» http://www.ncbi.nlm.nih.gov/sites/
Toon meer